The quick of it: stage, histology, and availability are the major factors impacting my decision on PETCT vs. CT scan.In most cases of stage IB1-IVA (FIGO 2018 staging, Bhatla et al., PMID 30656645), any histology, I prefer a PETCT when possible to ensure that no distant disease as well as to evaluat...

It's a valuable tool to know if nodal or pulmonary mets and pretty essential for locally advanced disease. Not always able to get insurance to cover despite its ability to identify mets not visible on CT.

At our institution, PETCT vs CT is also largely dependent on insurance status/availability with PETCT often favored. However, the newly published SENTIREC trial was alarming (at least to me!) in that "the sensitivity of FDG-PET/CT was 14.8%". The authors then reference several previous studies that ...